Last week, Bloomberg ran a very encouraging story headlined, “BioNTech’s Loss Is Wider Than Expected as Vaccine Sales Hurt.” Poor babies. I wonder what could be hurting vaccine sales? Probably those wily anti-vaxxers again, misinforming everybody.
article, it lost $886 million dollars last quarter. Almost a billion bucks, in one quarter. That shocking shortfall was over four times as much as the company’s $208 million loss from the second quarter of 2023.
Things seem to be headed in the wrong financial direction. Baffling.
But don’t worry too much about BioNTech. They are sitting on cash reserves of $20 billion dollars, and have a new slew of safe and effective mRNA cancer drugs ‘in the pipeline.’ And it plans for a robust fourth quarter this year, since it partnered with Pfizer on a one-shot flu-covid combo jab. It’s almost there, but not quite. Whoopsies:
Call me crazy, but even if they manage to get the FDA’s rubber stamp of approval, I’m not so sure the flu/covid combo shot will actually take the market by storm. Sure, there are a bunch of die-hard medical fetishists out there desperate to snap up a few doses, but as for me and my family, that is a hard pass. I would rather inject bleach.
Into my eyeball.
But you do you! Let me know in the comments if you can’t wait to get the new and improved, even safer, twice as effective, double mRNA shots this fall.
(PS—I really hate gloating like this, sort of, but I warned them, repeatedly and often, that this forced vaccine scheme of theirs would backfire. I told them so.)
article, it lost $886 million dollars last quarter. Almost a billion bucks, in one quarter. That shocking shortfall was over four times as much as the company’s $208 million loss from the second quarter of 2023.
Things seem to be headed in the wrong financial direction. Baffling.
But don’t worry too much about BioNTech. They are sitting on cash reserves of $20 billion dollars, and have a new slew of safe and effective mRNA cancer drugs ‘in the pipeline.’ And it plans for a robust fourth quarter this year, since it partnered with Pfizer on a one-shot flu-covid combo jab. It’s almost there, but not quite. Whoopsies:
Call me crazy, but even if they manage to get the FDA’s rubber stamp of approval, I’m not so sure the flu/covid combo shot will actually take the market by storm. Sure, there are a bunch of die-hard medical fetishists out there desperate to snap up a few doses, but as for me and my family, that is a hard pass. I would rather inject bleach.
Into my eyeball.
But you do you! Let me know in the comments if you can’t wait to get the new and improved, even safer, twice as effective, double mRNA shots this fall.
(PS—I really hate gloating like this, sort of, but I warned them, repeatedly and often, that this forced vaccine scheme of theirs would backfire. I told them so.)
☕️ PROGRESSING BACKWARDS ☙ Friday, August 16, 2024 ☙ C&C NEWS 🦠
Ukraine flips script and invades Russia back; Team Biden negotiates Middle East into a paper bag; hackers nab everybody's social security number, so that's that; combo jabs stumble over sandbag; more.
www.coffeeandcovid.com